With polidocanol, it was possible to reduce the MIC as well as the MBC of methicillin, oxacillin, penicillin G, and ampicillin against resistant staphylococci. The strongest effects were obtained with methicillin and oxacillin. All strains tested could be resensitized to these penicillins independent of the original resistance levels. Polidocanol was not inhibitory by itself for Staphylococcus aureus. Furthermore, it did not inhibit the activity of staphylococcal ,-lactamase. This permits the conclusion that an intrinsic resistance mechanism is affected by this substance. Its action cannot be simply explained by an improved accessibility of the penicillin targets as uptake, and binding of methicillin and penicillin G in resistant cells was not changed by polidocanol. On the other hand, the lysis indpced by combinations of this substance with small amounts of a penicillin was antagonized by chloramphenicol. This suggests that autolytic enzymes are involved in the polidocanol effect and possibly in the intrinsic resistance mechanism itself. Before polidocanol can trigger lysis, the penicillin must act first in some way. As could be seen with a susceptible strain, the resulting lysis did not exceed that obtained with penicillins alone. Thus, polidocanol does not exhibit an independent lytic mechanism but obviously is able to substitute penicillins in their lytic action.Bacterial resistance to penicillins can be expressed phenotypically in different ways. The most common type of penicillin resistance is that based on the inactivation of penicillins by J-lactamases. Besides this, enzyme-independent mechanisms exist which are termed intrinsic resistance. In staphylococci, the most typical form is resistance to methicillin (and oxacillin). Although altered penicillin-binding properties were recently found in resistant staphylococci (4,5,12,13), the mechanism of methicillin resistance is still unclear. In gram-negative bacteria, intrinsic resistance is due to a permeability barrier in the outer membrane (23). A special form of penicillin insensitivity is the so-called tolerance described by Sabath et al. (27) and characterized by low MICs but high MBCs of penicillins.Many successful efforts have been made to overcome the ,-lactamase-mediated type of penicillin resistance. In contrast, it was not possible until now to influence the methicillin resistance in staphylococci.In this paper, we report on the suppression of resistance to methicillin and oxacillin in Staphylococcus aureus by polidocanol (PDO). Resistance to penicillin G and ampicillin was also affected but to a lower extent. The activity of 1-lactamase, however, was not inhibited by PDO, indicating that its action is directed against an intrinsic resistance mechanism. Lysis induced by combinations of PDO and penicillins could be inhibited by chloramphenicol (CAP).This finding points to the participation of autolytic enzymes in the PDO effect and possibly in the resistance mechanism itself.
Summary. The synthesis and excretion of fl lactamase by several strains of StaphyZococcus aureus from different clinical sources and the ability of both the extracellular and membrane-bound enzyme to mediate penicillin resistance was studied. When p-lactamase production was maximally induced with penicillin G or ampicillin, about 50% of the p lactamase was excreted from the cells, the amount of extracellular enzyme correlating well with the degree of resistance established by an in-vitro test model. From penicillin-binding experiments it became apparent, however, that the membrane-bound p lactamase can also constitute a barrier, strong enough on its own to prevent penicillins from reaching their target. This could be of clinical relevance if, under certain conditions in vivo, the extracellular p lactamase is insufficient for full protect ion of the staphylococcal cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.